H-alpha-Me-D-Val-OH

H-alpha-Me-D-Val-OH is a chiral, amino-acid-derived intermediate corresponding to D-valine bearing an alpha-methyl substituent, giving a sterically constrained backbone with a secondary amino group and a free carboxylic acid. The added alpha-methyl group increases substitution at the stereogenic center relative to valine, which can influence conformational preferences and coupling behavior in peptide chemistry. The D-configuration provides stereochemical control for incorporation into peptide analogs, while the unprotected acid and amine functionality supports conversion to protected derivatives, activation for amide bond formation, and downstream derivatization. As an amino acid building block, H-alpha-Me-D-Val-OH functions as a stereodefined chiral intermediate for constructing modified peptide segments, evaluating structure-property relationships, and preparing functionalized valine analogs for synthetic organic and biochemical research workflows.

1. Peptide Synthesis

H-alpha-Me-D-Val-OH is applied in peptide building-block preparation where α-methyl substitution and D-stereochemistry enable the construction of sterically biased amide linkages and peptide analogs. The free carboxylic acid can be converted into activated esters or coupling-ready derivatives, while the amino functionality can be protected to control chemoselective peptide coupling at the desired N-terminus. The α-methyl group can modulate backbone conformations and can be used to probe how α-substitution affects folding, stability, and proteolytic susceptibility in peptide science. Incorporation into short peptides and peptidomimetic scaffolds supports structure-activity relationship studies and provides a defined chiral residue for synthetic methodology development.

2. Chiral Amino Acid Derivatization

H-alpha-Me-D-Val-OH is suitable for chiral amino acid derivatization and stereochemical intermediate synthesis in fine chemical production. The α-methyl-bearing stereocenter and the D-configuration allow access to diastereomerically informative derivatives when converted to N-protected forms or when used to generate chiral auxiliaries and analytical standards. The carboxylic acid can be esterified for solubility control during synthesis and later hydrolyzed for reactivation, while the amino group can be masked to tune reactivity during multi-step routes. Downstream formation of protected amino acid derivatives, activated intermediates, and labeled or functionalized variants supports industrial process chemistry intermediate preparation and chiral synthesis planning.

3. Side-Chain Functionalization

H-alpha-Me-D-Val-OH is used in side-chain functionalization workflows where valine's isopropyl side chain serves as a hydrophobic handle for constructing constrained amino acid analogs. The α-methyl substitution adds steric bulk near the backbone, which can influence coupling kinetics and the behavior of the residue during selective transformations on protected derivatives. Derivatization strategies can include conversion to N-protected amino acids followed by targeted modifications after peptide coupling or during orthogonal protection/deprotection sequences. The resulting functionalized amino acid derivatives can feed into peptidomimetic construction, molecular design for binding studies, and synthetic routes that require stereodefined hydrophobic residues.

4. Chemical Biology Probes

H-alpha-Me-D-Val-OH can be employed in chemical biology research as a stereodefined residue for labeling, probe design, and biomolecule interaction studies. The amino acid framework supports conversion into N-protected intermediates that can be incorporated into peptides or used to generate conjugation-ready derivatives through controlled activation of the carboxyl group. D-configuration and α-methyl substitution can be leveraged to tune resistance to enzymatic processing and to study how backbone constraints affect molecular recognition. Downstream use includes preparation of peptide-based probes, affinity reagents, and stereochemically defined analogs for biochemical assays and mechanistic investigations.

5. Pharmaceutical Intermediate Preparation

H-alpha-Me-D-Val-OH is applicable to pharmaceutical intermediate preparation where modified amino acid residues are required for synthetic routes to peptidomimetics and constrained peptide-like structures. The free carboxylic acid enables formation of coupling intermediates under controlled activation conditions, while N-protection strategies support orthogonal chemistry during multi-residue assembly. The α-methyl and D-stereochemistry provide a defined stereochemical element that can be carried through downstream synthesis to generate drug-candidate scaffolds and reference materials for medicinal chemistry. Process-relevant handling of amino acid derivatives, including ester/acid interconversions and protected amino acid synthesis, supports scalable fine chemical manufacturing of chiral intermediates.

1. C-Peptide replacement therapy and sensory nerve function in type 1 diabetic neuropathy

2. Application of human liver organoids as a patient-derived primary model for HBV infection and related hepatocellular carcinoma

3. Emerging applications of nanotechnology for diagnosis and therapy of disease: a review

4. Myotropic activity and immunolocalization of selected neuropeptides of the burying beetle Nicrophorus vespilloides (Coleoptera: Silphidae)

5. The effect of sex on immune responses to a homocitrullinated peptide in the DR4-transgenic mouse model of Rheumatoid Arthritis